| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.00071 | 1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |